http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1057978-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b6fc801b5bfe5304ffa40d938db6e09 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-06 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-263 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-76 |
| filingDate | 1965-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1967-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1057978-A |
| titleOfInvention | New sulphonyl urea derivatives |
| abstract | Novel sulphonyl ureas of the formula <FORM:1057978/C2/1> wherein n is 1, 2 or 3, R1 is hydrogen or a halogen up to atomic number 35, e.g. F or Cl, and R2 is hydrogen or a C1- 4 alkyl group, are made by reacting the appropriate phenyl isocyanate with the corresponding 2-oxo-piperidine, hexahydroazepine or octahydro-azocine. The products may be converted into their salts with inorganic or organic bases, e.g. alkali or alkaline earth hydroxides, carbonates or bicarbonates, triethanolamine, chloine or N1,N1-dimethyl- or N1-phenylethyl-biguanide. Pharmaceutical preparations for treatment of diabetes, comprise the above sulphonyl ureas and a carrier, preferably in a form adapted to oral administration. |
| priorityDate | 1964-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.